Anna Atlante

Dr. Anna Atlante

Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies, National Council of Research, Bari, Italy
orcid

Research Focus & Metrics

Academic Career Length

43Years (1984-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 May 2001 in FEBS Letters
Verified
Journal Article
Closed access
Anna AtlanteAnna Atlante
Anna Atlante
PCPietro Calissano
Pietro Calissano
ABAntonella Bobba
Antonella Bobba
Sergio GiannattasioSergio Giannattasio
Sergio Giannattasio
EMErsilia Marra
Ersilia Marra
SPSalvatore Passarella
Salvatore Passarella

1 January 2015 in Mitochondrion
Verified
Journal Article
Open access
ADAnna Maria D'Erchia
Anna Maria D'Erchia
Anna AtlanteAnna Atlante
Anna Atlante
GGGemma Gadaleta
Gemma Gadaleta
GPGiulio Pavesi
Giulio Pavesi
MCMATTEO CHIARA
MATTEO CHIARA
Graziano PesoleGraziano Pesole
Graziano Pesole
Eukaryotic cells contain a population of mitochondria, variable in number and shape, which in turn contain multiple copies of a tiny compact genome (mtDNA) whose expression and function is strictly coordinated with the nuclear one. mtDNA copy number varies between different cell or tissues types, both in response to overall metabolic and bioenergetics demands and as a consequence or cause of specific pathological conditions. Here we present a novel and reliable methodology to assess the effective mtDNA copy number per diploid genome by investigating off-target reads obtained by whole-exome sequencing (WES) experiments. We also investigate whether and how mtDNA copy number correlates with mitochondrial mass, respiratory activity and expression levels. Analyzing six different tissues from three age- and sex-matched human individuals, we found a highly significant linear correlation between mtDNA copy number estimated by qPCR and the frequency of mtDNA off target WES reads. Furthermore, mtDNA copy number showed highly significant correlation with mitochondrial gene expression levels as measured by RNA-Seq as well as with mitochondrial mass and respiratory activity. Our methodology makes thus feasible, at a large scale, the investigation of mtDNA copy number in diverse cell-types, tissues and pathological conditions or in response to specific treatments.

1 November 2000 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
Anna AtlanteAnna Atlante
Anna Atlante
PCPietro Calissano
Pietro Calissano
ABAntonella Bobba
Antonella Bobba
Amalia AzzaritiAmalia Azzariti
Amalia Azzariti
EMErsilia Marra
Ersilia Marra
SPSalvatore Passarella
Salvatore Passarella
In rat cerebellar granule cells both reactive oxygen species production and release of cytochrome c take place during glutamate toxicity. This investigation was aimed (i) to ascertain whether and how these two processes are related and (ii) to gain insight into the role played by the released cytochrome c in the onset of neurotoxicity. Cytochrome c release takes place owing to the generation of reactive oxygen species both in glutamate-treated cerebellar granule cells and in sister control cultures incubated in the presence of the reactive oxygen species-generating system consisting of xanthine plus xanthine oxidase. In the early phase of neurotoxicity (30-min glutamate exposure) about 40% of the maximum (as measured at 3 h of glutamate exposure) cytochrome c release was found to occur in cerebellar granule cells from mitochondria that were essentially coupled and intact and that had a negligible production of oxygen free radicals. Contrarily, mitochondria from cells treated with glutamate for 3 h were mostly uncoupled and produced reactive oxygen species at a high rate. The cytosolic fraction containing the released cytochrome c was able to transfer electrons from superoxide anion to molecular oxygen via the respiratory chain and was found to partially prevent glutamate toxicity when added externally to cerebellar neurons undergoing necrosis. In the light of these findings, we propose that in the early phase of neurotoxicity, cytochromec release can be part of a cellular and mitochondrial defense mechanism against oxidative stress.

29 October 2008 in FEBS Letters
Verified
Journal Article
Closed access
SPSalvatore Passarella
Salvatore Passarella
Lidia de BariLidia de Bari
Lidia de Bari
DVDaniela Valenti
Daniela Valenti
RPRoberto Pizzuto
Roberto Pizzuto
Gianluca PaventiGianluca Paventi
Gianluca Paventi
Anna AtlanteAnna Atlante
Anna Atlante

1 July 2013 in Mitochondrion
Verified
Journal Article
Closed access
ABA. Bobba
A. Bobba
Giuseppina AmadoroGiuseppina Amadoro
Giuseppina Amadoro
DVDaniela Valenti
Daniela Valenti
VCVeronica Corsetti
Veronica Corsetti
RLR. Lassandro
R. Lassandro
Anna AtlanteAnna Atlante
Anna Atlante

15 February 2015 in Human Molecular Genetics
Verified
Journal Article
Open access
PDF file
VCVeronica Corsetti
Veronica Corsetti
FFF. Florenzano
F. Florenzano
Anna AtlanteAnna Atlante
Anna Atlante
ABA. Bobba
A. Bobba
MCM.T. Ciotti
M.T. Ciotti
Giuseppina AmadoroGiuseppina Amadoro
Giuseppina Amadoro
Disarrangement in functions and quality control of mitochondria at synapses are early events in Alzheimer's disease (AD) pathobiology. We reported that a 20–22 kDa NH2-tau fragment mapping between 26 and 230 amino acids of the longest human tau isoform (aka NH2htau): (i) is detectable in cellular and animal AD models, as well in synaptic mitochondria and cerebrospinal fluids (CSF) from human AD subjects; (ii) is neurotoxic in primary hippocampal neurons; (iii) compromises the mitochondrial biology both directly, by inhibiting the ANT-1-dependent ADP/ATP exchange, and indirectly, by impairing their selective autophagic clearance (mitophagy). Here, we show that the extensive Parkin-dependent turnover of mitochondria occurring in NH2htau-expressing post-mitotic neurons plays a pro-death role and that UCHL-1, the cytosolic Ubiquitin-C-terminal hydrolase L1 which directs the physiological remodeling of synapses by controlling ubiquitin homeostasis, critically contributes to mitochondrial and synaptic failure in this in vitro AD model. Pharmacological or genetic suppression of improper mitophagy, either by inhibition of mitochondrial targeting to autophagosomes or by shRNA-mediated silencing of Parkin or UCHL-1 gene expression, restores synaptic and mitochondrial content providing partial but significant protection against the NH2htau-induced neuronal death. Moreover, in mitochondria from human AD synapses, the endogenous NH2htau is stably associated with Parkin and with UCHL-1. Taken together, our studies show a causative link between the excessive mitochondrial turnover and the NH2htau-induced in vitro neuronal death, suggesting that pathogenetic tau truncation may contribute to synaptic deterioration in AD by aberrant recruitment of Parkin and UCHL-1 to mitochondria making them more prone to detrimental autophagic clearance.